The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control

Aim. To characterize the plasma levels of vascular endothelial growth factor (VEGF) in type 1 diabetes mellitus (T1D) and its relation to both present and historical metabolic control and microvascular complications. Methods. Plasma levels of VEGF and routine clinical parameters were analyzed in 115...

Full description

Saved in:
Bibliographic Details
Main Authors: Kailash Singh, Stellan Sandler, Daniel Espes
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2017/6192896
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549621259304960
author Kailash Singh
Stellan Sandler
Daniel Espes
author_facet Kailash Singh
Stellan Sandler
Daniel Espes
author_sort Kailash Singh
collection DOAJ
description Aim. To characterize the plasma levels of vascular endothelial growth factor (VEGF) in type 1 diabetes mellitus (T1D) and its relation to both present and historical metabolic control and microvascular complications. Methods. Plasma levels of VEGF and routine clinical parameters were analyzed in 115 patients with long-standing T1D and 45 healthy controls (HC). All patients were under clinical routine diabetes treatment at Uppsala University Hospital. Results. The plasma levels of VEGF were increased by 37% in patients with T1D when compared to HC (18.2±0.8 versus 13.2±1.0 pg/ml, p<0.001). The levels of VEGF correlated to insulin needs and BMI but not to present or historical metabolic control. The levels of VEGF were similar in patients with T1D and microvascular complications (microalbuminuria and retinopathy) when compared with patients without microvascular complications. Historical HbA1c levels were found to be the best predictor for present metabolic control. Conclusion. Circulating plasma levels of VEGF do not correlate to present or historical metabolic control in long-standing T1D and the levels are not affected by the presence of microvascular complications.
format Article
id doaj-art-e78090740401476285a7db8b84dd07e0
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-e78090740401476285a7db8b84dd07e02025-02-03T06:11:00ZengWileyJournal of Diabetes Research2314-67452314-67532017-01-01201710.1155/2017/61928966192896The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic ControlKailash Singh0Stellan Sandler1Daniel Espes2Department of Medical Cell Biology, Uppsala University, Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, Uppsala, SwedenAim. To characterize the plasma levels of vascular endothelial growth factor (VEGF) in type 1 diabetes mellitus (T1D) and its relation to both present and historical metabolic control and microvascular complications. Methods. Plasma levels of VEGF and routine clinical parameters were analyzed in 115 patients with long-standing T1D and 45 healthy controls (HC). All patients were under clinical routine diabetes treatment at Uppsala University Hospital. Results. The plasma levels of VEGF were increased by 37% in patients with T1D when compared to HC (18.2±0.8 versus 13.2±1.0 pg/ml, p<0.001). The levels of VEGF correlated to insulin needs and BMI but not to present or historical metabolic control. The levels of VEGF were similar in patients with T1D and microvascular complications (microalbuminuria and retinopathy) when compared with patients without microvascular complications. Historical HbA1c levels were found to be the best predictor for present metabolic control. Conclusion. Circulating plasma levels of VEGF do not correlate to present or historical metabolic control in long-standing T1D and the levels are not affected by the presence of microvascular complications.http://dx.doi.org/10.1155/2017/6192896
spellingShingle Kailash Singh
Stellan Sandler
Daniel Espes
The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
Journal of Diabetes Research
title The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
title_full The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
title_fullStr The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
title_full_unstemmed The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
title_short The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
title_sort increased circulating plasma levels of vascular endothelial growth factor in patients with type 1 diabetes do not correlate to metabolic control
url http://dx.doi.org/10.1155/2017/6192896
work_keys_str_mv AT kailashsingh theincreasedcirculatingplasmalevelsofvascularendothelialgrowthfactorinpatientswithtype1diabetesdonotcorrelatetometaboliccontrol
AT stellansandler theincreasedcirculatingplasmalevelsofvascularendothelialgrowthfactorinpatientswithtype1diabetesdonotcorrelatetometaboliccontrol
AT danielespes theincreasedcirculatingplasmalevelsofvascularendothelialgrowthfactorinpatientswithtype1diabetesdonotcorrelatetometaboliccontrol
AT kailashsingh increasedcirculatingplasmalevelsofvascularendothelialgrowthfactorinpatientswithtype1diabetesdonotcorrelatetometaboliccontrol
AT stellansandler increasedcirculatingplasmalevelsofvascularendothelialgrowthfactorinpatientswithtype1diabetesdonotcorrelatetometaboliccontrol
AT danielespes increasedcirculatingplasmalevelsofvascularendothelialgrowthfactorinpatientswithtype1diabetesdonotcorrelatetometaboliccontrol